nodes	percent_of_prediction	percent_of_DWPC	metapath
Paliperidone—CYP3A4—Thiotepa—sarcoma	0.0548	0.255	CbGbCtD
Paliperidone—HTR1D—meninx—sarcoma	0.043	0.212	CbGeAlD
Paliperidone—CYP3A5—Vincristine—sarcoma	0.0416	0.193	CbGbCtD
Paliperidone—HTR1B—dura mater—sarcoma	0.0409	0.202	CbGeAlD
Paliperidone—HTR1D—dura mater—sarcoma	0.0396	0.195	CbGeAlD
Paliperidone—CYP3A5—Etoposide—sarcoma	0.0381	0.177	CbGbCtD
Paliperidone—CYP3A4—Mitoxantrone—sarcoma	0.0235	0.11	CbGbCtD
Paliperidone—CYP3A4—Vincristine—sarcoma	0.0162	0.0754	CbGbCtD
Paliperidone—CYP2D6—Doxorubicin—sarcoma	0.0159	0.0741	CbGbCtD
Paliperidone—CYP3A4—Etoposide—sarcoma	0.0149	0.0691	CbGbCtD
Paliperidone—CYP3A4—Doxorubicin—sarcoma	0.0101	0.0471	CbGbCtD
Paliperidone—HTR2A—pulmonary artery—sarcoma	0.0084	0.0414	CbGeAlD
Paliperidone—HTR2A—hindlimb—sarcoma	0.00508	0.0251	CbGeAlD
Paliperidone—HTR2A—appendage—sarcoma	0.00436	0.0215	CbGeAlD
Paliperidone—DRD4—testis—sarcoma	0.00361	0.0178	CbGeAlD
Paliperidone—HTR2A—endothelium—sarcoma	0.00263	0.013	CbGeAlD
Paliperidone—HTR1D—connective tissue—sarcoma	0.0025	0.0123	CbGeAlD
Paliperidone—ADRA2C—myometrium—sarcoma	0.00222	0.0109	CbGeAlD
Paliperidone—HTR1A—hematopoietic system—sarcoma	0.00217	0.0107	CbGeAlD
Paliperidone—ADRA2C—seminal vesicle—sarcoma	0.002	0.00988	CbGeAlD
Paliperidone—ADRA1A—hematopoietic system—sarcoma	0.002	0.00985	CbGeAlD
Paliperidone—HRH1—myometrium—sarcoma	0.0018	0.00888	CbGeAlD
Paliperidone—ADRA2A—myometrium—sarcoma	0.00177	0.00873	CbGeAlD
Paliperidone—ADRA2A—seminal vesicle—sarcoma	0.0016	0.00788	CbGeAlD
Paliperidone—CYP3A5—hematopoietic system—sarcoma	0.00159	0.00786	CbGeAlD
Paliperidone—HRH1—hematopoietic system—sarcoma	0.00155	0.00763	CbGeAlD
Paliperidone—ADRA2A—hematopoietic system—sarcoma	0.00152	0.00749	CbGeAlD
Paliperidone—HRH1—connective tissue—sarcoma	0.00149	0.00734	CbGeAlD
Paliperidone—ADRA2A—connective tissue—sarcoma	0.00146	0.00721	CbGeAlD
Paliperidone—HTR2A—embryo—sarcoma	0.00145	0.00714	CbGeAlD
Paliperidone—ADRA2C—cardiac atrium—sarcoma	0.00145	0.00713	CbGeAlD
Paliperidone—ADRA2C—uterus—sarcoma	0.00144	0.00709	CbGeAlD
Paliperidone—ADRA1A—lymphoid tissue—sarcoma	0.00141	0.00694	CbGeAlD
Paliperidone—HRH1—smooth muscle tissue—sarcoma	0.00136	0.00672	CbGeAlD
Paliperidone—HTR2A—hematopoietic system—sarcoma	0.00129	0.00637	CbGeAlD
Paliperidone—ADRA2C—tendon—sarcoma	0.00126	0.00621	CbGeAlD
Paliperidone—HTR2A—connective tissue—sarcoma	0.00124	0.00613	CbGeAlD
Paliperidone—CYP3A4—hematopoietic system—sarcoma	0.0012	0.0059	CbGeAlD
Paliperidone—CYP2D6—hematopoietic system—sarcoma	0.00118	0.0058	CbGeAlD
Paliperidone—ADRA2A—cardiac atrium—sarcoma	0.00115	0.00569	CbGeAlD
Paliperidone—ADRA2A—uterus—sarcoma	0.00115	0.00566	CbGeAlD
Paliperidone—HTR2A—smooth muscle tissue—sarcoma	0.00114	0.00561	CbGeAlD
Paliperidone—DRD2—testis—sarcoma	0.00107	0.00529	CbGeAlD
Paliperidone—ADRA2C—testis—sarcoma	0.00104	0.00515	CbGeAlD
Paliperidone—ADRA1A—liver—sarcoma	0.00104	0.0051	CbGeAlD
Paliperidone—HRH1—tendon—sarcoma	0.00102	0.00505	CbGeAlD
Paliperidone—ADRA2A—tendon—sarcoma	0.00101	0.00496	CbGeAlD
Paliperidone—ADRA2C—liver—sarcoma	0.000986	0.00486	CbGeAlD
Paliperidone—HTR2A—tendon—sarcoma	0.000855	0.00422	CbGeAlD
Paliperidone—HRH1—testis—sarcoma	0.000848	0.00418	CbGeAlD
Paliperidone—ADRA2A—testis—sarcoma	0.000832	0.00411	CbGeAlD
Paliperidone—CYP3A5—liver—sarcoma	0.000826	0.00407	CbGeAlD
Paliperidone—ADRA2C—lymph node—sarcoma	0.000756	0.00373	CbGeAlD
Paliperidone—HTR2A—testis—sarcoma	0.000708	0.00349	CbGeAlD
Paliperidone—HTR2A—liver—sarcoma	0.000669	0.0033	CbGeAlD
Paliperidone—CYP2D6—testis—sarcoma	0.000645	0.00318	CbGeAlD
Paliperidone—CYP3A4—liver—sarcoma	0.00062	0.00306	CbGeAlD
Paliperidone—HRH1—lymph node—sarcoma	0.000614	0.00303	CbGeAlD
Paliperidone—CYP2D6—liver—sarcoma	0.00061	0.00301	CbGeAlD
Paliperidone—ADRA2A—lymph node—sarcoma	0.000603	0.00298	CbGeAlD
Paliperidone—Neutropenia—Epirubicin—sarcoma	0.000527	0.000906	CcSEcCtD
Paliperidone—Dizziness—Thiotepa—sarcoma	0.000527	0.000905	CcSEcCtD
Paliperidone—Upper respiratory tract infection—Epirubicin—sarcoma	0.000524	0.0009	CcSEcCtD
Paliperidone—Influenza—Doxorubicin—sarcoma	0.000522	0.000896	CcSEcCtD
Paliperidone—Dysphagia—Doxorubicin—sarcoma	0.000522	0.000896	CcSEcCtD
Paliperidone—Pollakiuria—Epirubicin—sarcoma	0.000521	0.000895	CcSEcCtD
Paliperidone—Hypersensitivity—Vincristine—sarcoma	0.00052	0.000894	CcSEcCtD
Paliperidone—Paraesthesia—Etoposide—sarcoma	0.000514	0.000882	CcSEcCtD
Paliperidone—Weight increased—Epirubicin—sarcoma	0.000513	0.000881	CcSEcCtD
Paliperidone—Pancreatitis—Doxorubicin—sarcoma	0.000512	0.000879	CcSEcCtD
Paliperidone—Weight decreased—Epirubicin—sarcoma	0.00051	0.000876	CcSEcCtD
Paliperidone—Dyspnoea—Etoposide—sarcoma	0.00051	0.000876	CcSEcCtD
Paliperidone—Hyperglycaemia—Epirubicin—sarcoma	0.000509	0.000874	CcSEcCtD
Paliperidone—Somnolence—Etoposide—sarcoma	0.000509	0.000874	CcSEcCtD
Paliperidone—Hypersensitivity—Mitoxantrone—sarcoma	0.000507	0.00087	CcSEcCtD
Paliperidone—Asthenia—Vincristine—sarcoma	0.000507	0.00087	CcSEcCtD
Paliperidone—Vomiting—Thiotepa—sarcoma	0.000506	0.00087	CcSEcCtD
Paliperidone—Pneumonia—Epirubicin—sarcoma	0.000506	0.000869	CcSEcCtD
Paliperidone—Infestation—Epirubicin—sarcoma	0.000503	0.000864	CcSEcCtD
Paliperidone—Infestation NOS—Epirubicin—sarcoma	0.000503	0.000864	CcSEcCtD
Paliperidone—Vomiting—Dactinomycin—sarcoma	0.000503	0.000863	CcSEcCtD
Paliperidone—Rash—Thiotepa—sarcoma	0.000502	0.000862	CcSEcCtD
Paliperidone—Bronchitis—Doxorubicin—sarcoma	0.000502	0.000862	CcSEcCtD
Paliperidone—Dermatitis—Thiotepa—sarcoma	0.000502	0.000862	CcSEcCtD
Paliperidone—Headache—Thiotepa—sarcoma	0.000499	0.000857	CcSEcCtD
Paliperidone—Rash—Dactinomycin—sarcoma	0.000498	0.000856	CcSEcCtD
Paliperidone—Decreased appetite—Etoposide—sarcoma	0.000497	0.000854	CcSEcCtD
Paliperidone—Gastrointestinal disorder—Etoposide—sarcoma	0.000494	0.000848	CcSEcCtD
Paliperidone—Asthenia—Mitoxantrone—sarcoma	0.000493	0.000848	CcSEcCtD
Paliperidone—Fatigue—Etoposide—sarcoma	0.000493	0.000847	CcSEcCtD
Paliperidone—Jaundice—Epirubicin—sarcoma	0.00049	0.000842	CcSEcCtD
Paliperidone—Constipation—Etoposide—sarcoma	0.000489	0.00084	CcSEcCtD
Paliperidone—Pain—Etoposide—sarcoma	0.000489	0.00084	CcSEcCtD
Paliperidone—Urinary tract infection—Epirubicin—sarcoma	0.000489	0.000839	CcSEcCtD
Paliperidone—Conjunctivitis—Epirubicin—sarcoma	0.000489	0.000839	CcSEcCtD
Paliperidone—Dysuria—Doxorubicin—sarcoma	0.000488	0.000838	CcSEcCtD
Paliperidone—Neutropenia—Doxorubicin—sarcoma	0.000488	0.000838	CcSEcCtD
Paliperidone—Upper respiratory tract infection—Doxorubicin—sarcoma	0.000485	0.000833	CcSEcCtD
Paliperidone—Diarrhoea—Vincristine—sarcoma	0.000483	0.00083	CcSEcCtD
Paliperidone—Pollakiuria—Doxorubicin—sarcoma	0.000482	0.000828	CcSEcCtD
Paliperidone—Hepatobiliary disease—Epirubicin—sarcoma	0.000476	0.000817	CcSEcCtD
Paliperidone—Weight increased—Doxorubicin—sarcoma	0.000475	0.000816	CcSEcCtD
Paliperidone—Epistaxis—Epirubicin—sarcoma	0.000474	0.000815	CcSEcCtD
Paliperidone—Nausea—Thiotepa—sarcoma	0.000473	0.000813	CcSEcCtD
Paliperidone—Weight decreased—Doxorubicin—sarcoma	0.000472	0.000811	CcSEcCtD
Paliperidone—Sinusitis—Epirubicin—sarcoma	0.000472	0.00081	CcSEcCtD
Paliperidone—Feeling abnormal—Etoposide—sarcoma	0.000471	0.00081	CcSEcCtD
Paliperidone—Hyperglycaemia—Doxorubicin—sarcoma	0.000471	0.000808	CcSEcCtD
Paliperidone—Diarrhoea—Mitoxantrone—sarcoma	0.000471	0.000808	CcSEcCtD
Paliperidone—Nausea—Dactinomycin—sarcoma	0.00047	0.000806	CcSEcCtD
Paliperidone—Agranulocytosis—Epirubicin—sarcoma	0.000469	0.000806	CcSEcCtD
Paliperidone—Pneumonia—Doxorubicin—sarcoma	0.000468	0.000804	CcSEcCtD
Paliperidone—Gastrointestinal pain—Etoposide—sarcoma	0.000468	0.000803	CcSEcCtD
Paliperidone—Dizziness—Vincristine—sarcoma	0.000467	0.000802	CcSEcCtD
Paliperidone—Infestation—Doxorubicin—sarcoma	0.000465	0.000799	CcSEcCtD
Paliperidone—Infestation NOS—Doxorubicin—sarcoma	0.000465	0.000799	CcSEcCtD
Paliperidone—Bradycardia—Epirubicin—sarcoma	0.00046	0.000789	CcSEcCtD
Paliperidone—Urticaria—Etoposide—sarcoma	0.000454	0.000781	CcSEcCtD
Paliperidone—Jaundice—Doxorubicin—sarcoma	0.000453	0.000779	CcSEcCtD
Paliperidone—Rhinitis—Epirubicin—sarcoma	0.000453	0.000777	CcSEcCtD
Paliperidone—Abdominal pain—Etoposide—sarcoma	0.000452	0.000777	CcSEcCtD
Paliperidone—Body temperature increased—Etoposide—sarcoma	0.000452	0.000777	CcSEcCtD
Paliperidone—Conjunctivitis—Doxorubicin—sarcoma	0.000452	0.000777	CcSEcCtD
Paliperidone—Urinary tract infection—Doxorubicin—sarcoma	0.000452	0.000777	CcSEcCtD
Paliperidone—Hypoaesthesia—Epirubicin—sarcoma	0.000449	0.000771	CcSEcCtD
Paliperidone—Vomiting—Vincristine—sarcoma	0.000449	0.000771	CcSEcCtD
Paliperidone—Urinary tract disorder—Epirubicin—sarcoma	0.000446	0.000766	CcSEcCtD
Paliperidone—Rash—Vincristine—sarcoma	0.000445	0.000765	CcSEcCtD
Paliperidone—Dermatitis—Vincristine—sarcoma	0.000445	0.000764	CcSEcCtD
Paliperidone—Oedema peripheral—Epirubicin—sarcoma	0.000445	0.000764	CcSEcCtD
Paliperidone—Connective tissue disorder—Epirubicin—sarcoma	0.000444	0.000762	CcSEcCtD
Paliperidone—Urethral disorder—Epirubicin—sarcoma	0.000442	0.00076	CcSEcCtD
Paliperidone—Headache—Vincristine—sarcoma	0.000442	0.00076	CcSEcCtD
Paliperidone—Hepatobiliary disease—Doxorubicin—sarcoma	0.00044	0.000756	CcSEcCtD
Paliperidone—Epistaxis—Doxorubicin—sarcoma	0.000439	0.000754	CcSEcCtD
Paliperidone—Vomiting—Mitoxantrone—sarcoma	0.000437	0.000751	CcSEcCtD
Paliperidone—Sinusitis—Doxorubicin—sarcoma	0.000436	0.00075	CcSEcCtD
Paliperidone—Agranulocytosis—Doxorubicin—sarcoma	0.000434	0.000746	CcSEcCtD
Paliperidone—Rash—Mitoxantrone—sarcoma	0.000434	0.000745	CcSEcCtD
Paliperidone—Dermatitis—Mitoxantrone—sarcoma	0.000433	0.000744	CcSEcCtD
Paliperidone—Headache—Mitoxantrone—sarcoma	0.000431	0.00074	CcSEcCtD
Paliperidone—Bradycardia—Doxorubicin—sarcoma	0.000425	0.00073	CcSEcCtD
Paliperidone—Eye disorder—Epirubicin—sarcoma	0.000422	0.000725	CcSEcCtD
Paliperidone—Hypersensitivity—Etoposide—sarcoma	0.000421	0.000724	CcSEcCtD
Paliperidone—Tinnitus—Epirubicin—sarcoma	0.000421	0.000723	CcSEcCtD
Paliperidone—Nausea—Vincristine—sarcoma	0.000419	0.00072	CcSEcCtD
Paliperidone—Cardiac disorder—Epirubicin—sarcoma	0.000419	0.00072	CcSEcCtD
Paliperidone—Flushing—Epirubicin—sarcoma	0.000419	0.00072	CcSEcCtD
Paliperidone—Rhinitis—Doxorubicin—sarcoma	0.000419	0.000719	CcSEcCtD
Paliperidone—Hypoaesthesia—Doxorubicin—sarcoma	0.000416	0.000714	CcSEcCtD
Paliperidone—Urinary tract disorder—Doxorubicin—sarcoma	0.000412	0.000708	CcSEcCtD
Paliperidone—Oedema peripheral—Doxorubicin—sarcoma	0.000411	0.000707	CcSEcCtD
Paliperidone—Asthenia—Etoposide—sarcoma	0.00041	0.000705	CcSEcCtD
Paliperidone—Connective tissue disorder—Doxorubicin—sarcoma	0.00041	0.000705	CcSEcCtD
Paliperidone—Angiopathy—Epirubicin—sarcoma	0.00041	0.000703	CcSEcCtD
Paliperidone—Urethral disorder—Doxorubicin—sarcoma	0.000409	0.000703	CcSEcCtD
Paliperidone—Nausea—Mitoxantrone—sarcoma	0.000409	0.000702	CcSEcCtD
Paliperidone—Immune system disorder—Epirubicin—sarcoma	0.000408	0.0007	CcSEcCtD
Paliperidone—Mediastinal disorder—Epirubicin—sarcoma	0.000407	0.000699	CcSEcCtD
Paliperidone—Chills—Epirubicin—sarcoma	0.000405	0.000696	CcSEcCtD
Paliperidone—Pruritus—Etoposide—sarcoma	0.000405	0.000695	CcSEcCtD
Paliperidone—Alopecia—Epirubicin—sarcoma	0.000399	0.000685	CcSEcCtD
Paliperidone—Mental disorder—Epirubicin—sarcoma	0.000395	0.000679	CcSEcCtD
Paliperidone—Malnutrition—Epirubicin—sarcoma	0.000393	0.000675	CcSEcCtD
Paliperidone—Erythema—Epirubicin—sarcoma	0.000393	0.000675	CcSEcCtD
Paliperidone—Diarrhoea—Etoposide—sarcoma	0.000391	0.000672	CcSEcCtD
Paliperidone—Eye disorder—Doxorubicin—sarcoma	0.00039	0.00067	CcSEcCtD
Paliperidone—Tinnitus—Doxorubicin—sarcoma	0.000389	0.000669	CcSEcCtD
Paliperidone—Cardiac disorder—Doxorubicin—sarcoma	0.000388	0.000666	CcSEcCtD
Paliperidone—Flushing—Doxorubicin—sarcoma	0.000388	0.000666	CcSEcCtD
Paliperidone—Flatulence—Epirubicin—sarcoma	0.000387	0.000665	CcSEcCtD
Paliperidone—Tension—Epirubicin—sarcoma	0.000386	0.000662	CcSEcCtD
Paliperidone—Dysgeusia—Epirubicin—sarcoma	0.000385	0.000661	CcSEcCtD
Paliperidone—Nervousness—Epirubicin—sarcoma	0.000382	0.000655	CcSEcCtD
Paliperidone—Back pain—Epirubicin—sarcoma	0.00038	0.000653	CcSEcCtD
Paliperidone—Angiopathy—Doxorubicin—sarcoma	0.000379	0.000651	CcSEcCtD
Paliperidone—Dizziness—Etoposide—sarcoma	0.000378	0.00065	CcSEcCtD
Paliperidone—Muscle spasms—Epirubicin—sarcoma	0.000378	0.000649	CcSEcCtD
Paliperidone—Immune system disorder—Doxorubicin—sarcoma	0.000377	0.000648	CcSEcCtD
Paliperidone—Mediastinal disorder—Doxorubicin—sarcoma	0.000376	0.000646	CcSEcCtD
Paliperidone—Chills—Doxorubicin—sarcoma	0.000375	0.000644	CcSEcCtD
Paliperidone—Vision blurred—Epirubicin—sarcoma	0.00037	0.000636	CcSEcCtD
Paliperidone—Alopecia—Doxorubicin—sarcoma	0.000369	0.000634	CcSEcCtD
Paliperidone—Mental disorder—Doxorubicin—sarcoma	0.000366	0.000628	CcSEcCtD
Paliperidone—Ill-defined disorder—Epirubicin—sarcoma	0.000365	0.000626	CcSEcCtD
Paliperidone—Vomiting—Etoposide—sarcoma	0.000364	0.000625	CcSEcCtD
Paliperidone—Erythema—Doxorubicin—sarcoma	0.000364	0.000624	CcSEcCtD
Paliperidone—Malnutrition—Doxorubicin—sarcoma	0.000364	0.000624	CcSEcCtD
Paliperidone—Anaemia—Epirubicin—sarcoma	0.000363	0.000624	CcSEcCtD
Paliperidone—Agitation—Epirubicin—sarcoma	0.000361	0.00062	CcSEcCtD
Paliperidone—Rash—Etoposide—sarcoma	0.000361	0.00062	CcSEcCtD
Paliperidone—Dermatitis—Etoposide—sarcoma	0.00036	0.000619	CcSEcCtD
Paliperidone—Headache—Etoposide—sarcoma	0.000358	0.000616	CcSEcCtD
Paliperidone—Flatulence—Doxorubicin—sarcoma	0.000358	0.000615	CcSEcCtD
Paliperidone—Tension—Doxorubicin—sarcoma	0.000357	0.000613	CcSEcCtD
Paliperidone—Dysgeusia—Doxorubicin—sarcoma	0.000356	0.000612	CcSEcCtD
Paliperidone—Malaise—Epirubicin—sarcoma	0.000354	0.000609	CcSEcCtD
Paliperidone—Nervousness—Doxorubicin—sarcoma	0.000353	0.000606	CcSEcCtD
Paliperidone—Vertigo—Epirubicin—sarcoma	0.000353	0.000606	CcSEcCtD
Paliperidone—Syncope—Epirubicin—sarcoma	0.000352	0.000605	CcSEcCtD
Paliperidone—Leukopenia—Epirubicin—sarcoma	0.000352	0.000604	CcSEcCtD
Paliperidone—Back pain—Doxorubicin—sarcoma	0.000352	0.000604	CcSEcCtD
Paliperidone—Muscle spasms—Doxorubicin—sarcoma	0.00035	0.0006	CcSEcCtD
Paliperidone—Palpitations—Epirubicin—sarcoma	0.000347	0.000596	CcSEcCtD
Paliperidone—Loss of consciousness—Epirubicin—sarcoma	0.000345	0.000593	CcSEcCtD
Paliperidone—Cough—Epirubicin—sarcoma	0.000343	0.000589	CcSEcCtD
Paliperidone—Vision blurred—Doxorubicin—sarcoma	0.000343	0.000588	CcSEcCtD
Paliperidone—Convulsion—Epirubicin—sarcoma	0.00034	0.000585	CcSEcCtD
Paliperidone—Nausea—Etoposide—sarcoma	0.00034	0.000584	CcSEcCtD
Paliperidone—Hypertension—Epirubicin—sarcoma	0.000339	0.000583	CcSEcCtD
Paliperidone—Ill-defined disorder—Doxorubicin—sarcoma	0.000337	0.000579	CcSEcCtD
Paliperidone—Anaemia—Doxorubicin—sarcoma	0.000336	0.000577	CcSEcCtD
Paliperidone—Arthralgia—Epirubicin—sarcoma	0.000335	0.000575	CcSEcCtD
Paliperidone—Chest pain—Epirubicin—sarcoma	0.000335	0.000575	CcSEcCtD
Paliperidone—Myalgia—Epirubicin—sarcoma	0.000335	0.000575	CcSEcCtD
Paliperidone—Agitation—Doxorubicin—sarcoma	0.000334	0.000574	CcSEcCtD
Paliperidone—Anxiety—Epirubicin—sarcoma	0.000333	0.000573	CcSEcCtD
Paliperidone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.000332	0.000571	CcSEcCtD
Paliperidone—Discomfort—Epirubicin—sarcoma	0.000331	0.000568	CcSEcCtD
Paliperidone—Malaise—Doxorubicin—sarcoma	0.000328	0.000563	CcSEcCtD
Paliperidone—Dry mouth—Epirubicin—sarcoma	0.000327	0.000562	CcSEcCtD
Paliperidone—Vertigo—Doxorubicin—sarcoma	0.000327	0.000561	CcSEcCtD
Paliperidone—Syncope—Doxorubicin—sarcoma	0.000326	0.00056	CcSEcCtD
Paliperidone—Leukopenia—Doxorubicin—sarcoma	0.000325	0.000559	CcSEcCtD
Paliperidone—Confusional state—Epirubicin—sarcoma	0.000323	0.000555	CcSEcCtD
Paliperidone—Palpitations—Doxorubicin—sarcoma	0.000321	0.000552	CcSEcCtD
Paliperidone—Oedema—Epirubicin—sarcoma	0.000321	0.000551	CcSEcCtD
Paliperidone—Anaphylactic shock—Epirubicin—sarcoma	0.000321	0.000551	CcSEcCtD
Paliperidone—Loss of consciousness—Doxorubicin—sarcoma	0.00032	0.000549	CcSEcCtD
Paliperidone—Infection—Epirubicin—sarcoma	0.000319	0.000547	CcSEcCtD
Paliperidone—Cough—Doxorubicin—sarcoma	0.000317	0.000545	CcSEcCtD
Paliperidone—Shock—Epirubicin—sarcoma	0.000315	0.000542	CcSEcCtD
Paliperidone—Convulsion—Doxorubicin—sarcoma	0.000315	0.000541	CcSEcCtD
Paliperidone—Nervous system disorder—Epirubicin—sarcoma	0.000314	0.00054	CcSEcCtD
Paliperidone—Thrombocytopenia—Epirubicin—sarcoma	0.000314	0.000539	CcSEcCtD
Paliperidone—Hypertension—Doxorubicin—sarcoma	0.000314	0.000539	CcSEcCtD
Paliperidone—Tachycardia—Epirubicin—sarcoma	0.000313	0.000538	CcSEcCtD
Paliperidone—Skin disorder—Epirubicin—sarcoma	0.000311	0.000535	CcSEcCtD
Paliperidone—Myalgia—Doxorubicin—sarcoma	0.00031	0.000532	CcSEcCtD
Paliperidone—Arthralgia—Doxorubicin—sarcoma	0.00031	0.000532	CcSEcCtD
Paliperidone—Chest pain—Doxorubicin—sarcoma	0.00031	0.000532	CcSEcCtD
Paliperidone—Anxiety—Doxorubicin—sarcoma	0.000308	0.00053	CcSEcCtD
Paliperidone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.000307	0.000528	CcSEcCtD
Paliperidone—Discomfort—Doxorubicin—sarcoma	0.000306	0.000525	CcSEcCtD
Paliperidone—Anorexia—Epirubicin—sarcoma	0.000306	0.000525	CcSEcCtD
Paliperidone—Dry mouth—Doxorubicin—sarcoma	0.000303	0.00052	CcSEcCtD
Paliperidone—Hypotension—Epirubicin—sarcoma	0.0003	0.000515	CcSEcCtD
Paliperidone—Confusional state—Doxorubicin—sarcoma	0.000299	0.000514	CcSEcCtD
Paliperidone—Oedema—Doxorubicin—sarcoma	0.000297	0.00051	CcSEcCtD
Paliperidone—Anaphylactic shock—Doxorubicin—sarcoma	0.000297	0.00051	CcSEcCtD
Paliperidone—Infection—Doxorubicin—sarcoma	0.000295	0.000506	CcSEcCtD
Paliperidone—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000292	0.000502	CcSEcCtD
Paliperidone—Shock—Doxorubicin—sarcoma	0.000292	0.000501	CcSEcCtD
Paliperidone—Nervous system disorder—Doxorubicin—sarcoma	0.000291	0.0005	CcSEcCtD
Paliperidone—Thrombocytopenia—Doxorubicin—sarcoma	0.000291	0.000499	CcSEcCtD
Paliperidone—Insomnia—Epirubicin—sarcoma	0.00029	0.000498	CcSEcCtD
Paliperidone—Tachycardia—Doxorubicin—sarcoma	0.00029	0.000497	CcSEcCtD
Paliperidone—Skin disorder—Doxorubicin—sarcoma	0.000288	0.000495	CcSEcCtD
Paliperidone—Paraesthesia—Epirubicin—sarcoma	0.000288	0.000495	CcSEcCtD
Paliperidone—Dyspnoea—Epirubicin—sarcoma	0.000286	0.000491	CcSEcCtD
Paliperidone—Somnolence—Epirubicin—sarcoma	0.000285	0.00049	CcSEcCtD
Paliperidone—Anorexia—Doxorubicin—sarcoma	0.000283	0.000486	CcSEcCtD
Paliperidone—Dyspepsia—Epirubicin—sarcoma	0.000282	0.000485	CcSEcCtD
Paliperidone—Decreased appetite—Epirubicin—sarcoma	0.000279	0.000479	CcSEcCtD
Paliperidone—Hypotension—Doxorubicin—sarcoma	0.000277	0.000476	CcSEcCtD
Paliperidone—Gastrointestinal disorder—Epirubicin—sarcoma	0.000277	0.000476	CcSEcCtD
Paliperidone—Fatigue—Epirubicin—sarcoma	0.000276	0.000475	CcSEcCtD
Paliperidone—Pain—Epirubicin—sarcoma	0.000274	0.000471	CcSEcCtD
Paliperidone—Constipation—Epirubicin—sarcoma	0.000274	0.000471	CcSEcCtD
Paliperidone—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.00027	0.000464	CcSEcCtD
Paliperidone—Insomnia—Doxorubicin—sarcoma	0.000268	0.000461	CcSEcCtD
Paliperidone—Paraesthesia—Doxorubicin—sarcoma	0.000266	0.000458	CcSEcCtD
Paliperidone—Dyspnoea—Doxorubicin—sarcoma	0.000265	0.000454	CcSEcCtD
Paliperidone—Feeling abnormal—Epirubicin—sarcoma	0.000264	0.000454	CcSEcCtD
Paliperidone—Somnolence—Doxorubicin—sarcoma	0.000264	0.000453	CcSEcCtD
Paliperidone—Gastrointestinal pain—Epirubicin—sarcoma	0.000262	0.00045	CcSEcCtD
Paliperidone—Dyspepsia—Doxorubicin—sarcoma	0.000261	0.000449	CcSEcCtD
Paliperidone—Decreased appetite—Doxorubicin—sarcoma	0.000258	0.000443	CcSEcCtD
Paliperidone—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000256	0.00044	CcSEcCtD
Paliperidone—Fatigue—Doxorubicin—sarcoma	0.000256	0.000439	CcSEcCtD
Paliperidone—Urticaria—Epirubicin—sarcoma	0.000255	0.000438	CcSEcCtD
Paliperidone—Pain—Doxorubicin—sarcoma	0.000254	0.000436	CcSEcCtD
Paliperidone—Constipation—Doxorubicin—sarcoma	0.000254	0.000436	CcSEcCtD
Paliperidone—Abdominal pain—Epirubicin—sarcoma	0.000254	0.000435	CcSEcCtD
Paliperidone—Body temperature increased—Epirubicin—sarcoma	0.000254	0.000435	CcSEcCtD
Paliperidone—Feeling abnormal—Doxorubicin—sarcoma	0.000245	0.00042	CcSEcCtD
Paliperidone—Gastrointestinal pain—Doxorubicin—sarcoma	0.000243	0.000417	CcSEcCtD
Paliperidone—Hypersensitivity—Epirubicin—sarcoma	0.000236	0.000406	CcSEcCtD
Paliperidone—Urticaria—Doxorubicin—sarcoma	0.000236	0.000405	CcSEcCtD
Paliperidone—Abdominal pain—Doxorubicin—sarcoma	0.000235	0.000403	CcSEcCtD
Paliperidone—Body temperature increased—Doxorubicin—sarcoma	0.000235	0.000403	CcSEcCtD
Paliperidone—Asthenia—Epirubicin—sarcoma	0.00023	0.000395	CcSEcCtD
Paliperidone—Pruritus—Epirubicin—sarcoma	0.000227	0.00039	CcSEcCtD
Paliperidone—Diarrhoea—Epirubicin—sarcoma	0.000219	0.000377	CcSEcCtD
Paliperidone—Hypersensitivity—Doxorubicin—sarcoma	0.000219	0.000375	CcSEcCtD
Paliperidone—Asthenia—Doxorubicin—sarcoma	0.000213	0.000366	CcSEcCtD
Paliperidone—Dizziness—Epirubicin—sarcoma	0.000212	0.000364	CcSEcCtD
Paliperidone—Pruritus—Doxorubicin—sarcoma	0.00021	0.000361	CcSEcCtD
Paliperidone—Vomiting—Epirubicin—sarcoma	0.000204	0.00035	CcSEcCtD
Paliperidone—Diarrhoea—Doxorubicin—sarcoma	0.000203	0.000349	CcSEcCtD
Paliperidone—Rash—Epirubicin—sarcoma	0.000202	0.000347	CcSEcCtD
Paliperidone—Dermatitis—Epirubicin—sarcoma	0.000202	0.000347	CcSEcCtD
Paliperidone—Headache—Epirubicin—sarcoma	0.000201	0.000345	CcSEcCtD
Paliperidone—Dizziness—Doxorubicin—sarcoma	0.000196	0.000337	CcSEcCtD
Paliperidone—Nausea—Epirubicin—sarcoma	0.00019	0.000327	CcSEcCtD
Paliperidone—Vomiting—Doxorubicin—sarcoma	0.000189	0.000324	CcSEcCtD
Paliperidone—Rash—Doxorubicin—sarcoma	0.000187	0.000321	CcSEcCtD
Paliperidone—Dermatitis—Doxorubicin—sarcoma	0.000187	0.000321	CcSEcCtD
Paliperidone—Headache—Doxorubicin—sarcoma	0.000186	0.000319	CcSEcCtD
Paliperidone—Nausea—Doxorubicin—sarcoma	0.000176	0.000303	CcSEcCtD
